Cerus (CERS) Affirms Revised FDA Guidance with Respect to Zika Virus Testing
Go back to Cerus (CERS) Affirms Revised FDA Guidance with Respect to Zika Virus Testing| Cerus Corp (NASDAQ: CERS) | Delayed: 1.68 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.68 | 52 Week High | $7.64 | |||
| Open | $1.68 | 52 Week Low | $4.22 | |||
| Day High | $1.71 | P/E | N/A | |||
| Day Low | $1.65 | EPS | $-0.59 | |||
| Volume | 83,393 | |||||
